HOKU-81 inhibits the signaling pathway between G-protein-coupled receptors (GPCRs) and G proteins. It targets beta-2 adrenergic receptor.
Molecular Weight
243.73
Molecular Formula
C12H18ClNO2
Targets
Beta-2 adrenergic receptor
Form
Lyophilized powder
Purity
>98%
Applications
HOKU-81 can be studied for its effect on promoting cardiovascular health by exerting vasodilatory effects, improving blood flow, and reducing inflammation and oxidative stress.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
